163 related articles for article (PubMed ID: 28577928)
21. Bacillus Calmette-Guérin failure in patients with non-muscle-invasive urothelial carcinoma of the bladder may be due to the urologist's failure to detect urothelial carcinoma of the upper urinary tract and urethra.
Giannarini G; Birkhäuser FD; Recker F; Thalmann GN; Studer UE
Eur Urol; 2014 Apr; 65(4):825-31. PubMed ID: 24144432
[TBL] [Abstract][Full Text] [Related]
22. [A case in which severely irritable bladder following intravesical instillation of Bacillus Calmette Guerin was successfully treated by steroid therapy].
Kimura K; Matsuura O; Isobe Y; Kamihira O; Kondo A
Nihon Hinyokika Gakkai Zasshi; 2003 Jul; 94(5):574-7. PubMed ID: 12910934
[TBL] [Abstract][Full Text] [Related]
23. Bladder contracture: review for intravesical bacillus Calmette-Guerin complication.
Hameed A; Sezian N; Thwaini A
Can J Urol; 2007 Dec; 14(6):3745-9. PubMed ID: 18163926
[TBL] [Abstract][Full Text] [Related]
24. The first case of bacillus Calmette-Guérin-induced small-vessel central nervous system vasculitis.
Parent ME; Richer M; Liang P
Clin Rheumatol; 2018 Aug; 37(8):2297-2302. PubMed ID: 29740727
[TBL] [Abstract][Full Text] [Related]
25. Eosinophilic cystitis induced by bacillus Calmette-Guerin (BCG) intravesical instillation.
Hidoussi A; Slama A; Jaidane M; Zakhama W; Youssef A; Ben Sorba N; Mosbah AF
Urology; 2007 Sep; 70(3):591.e9-10. PubMed ID: 17905131
[TBL] [Abstract][Full Text] [Related]
26. Disseminated tuberculosis in a patient with recurrent transitional cell carcinoma of renal pelvis and bladder following intravesical BCG therapy: A report of a rare case.
Pujani M; Khan S; Jetley S; Raina PK
J Cancer Res Ther; 2015; 11(4):1028. PubMed ID: 26881604
[TBL] [Abstract][Full Text] [Related]
27. The effect of age on the efficacy of maintenance bacillus Calmette-Guérin relative to maintenance epirubicin in patients with stage Ta T1 urothelial bladder cancer: results from EORTC genito-urinary group study 30911.
Oddens JR; Sylvester RJ; Brausi MA; Kirkels WJ; van de Beek C; van Andel G; de Reijke TM; Prescott S; Witjes JA; Oosterlinck W
Eur Urol; 2014 Oct; 66(4):694-701. PubMed ID: 24948466
[TBL] [Abstract][Full Text] [Related]
28. Is it possible to stop follow-up of patients with primary T1G3 urothelial carcinoma of the bladder managed with intravesical bacille Calmette-Guérin immunotherapy?
Golabek T; Palou J; Rodríguez O; Gaya JM; Breda A; Villavicencio H
World J Urol; 2017 Feb; 35(2):237-243. PubMed ID: 27277599
[TBL] [Abstract][Full Text] [Related]
29. Long-term results of intravesical bacillus Calmette-Guérin therapy for stage T1 superficial bladder cancer.
Droller MJ
J Urol; 2001 Feb; 165(2):701-2. PubMed ID: 11233047
[No Abstract] [Full Text] [Related]
30. A Rare Case of Granulomatous Pneumonitis Due to Intravesical BCG for Bladder Cancer.
Clérigo V; Castro A; Mourato T; Gomes C
Acta Med Port; 2019 Apr; 32(4):316-320. PubMed ID: 31067427
[TBL] [Abstract][Full Text] [Related]
31. Peritoneal tuberculosis caused by intravesical instillation with Bacillus Calmette-Guérin (BCG) following nephroureterectomy in a patient with bladder and upper tract urothelial cancer: a case report.
Allaeys C; De Backer P; Decaestecker K; Berquin C; Decaestecker K; Callens S; Van Praet C
Acta Clin Belg; 2023 Jun; 78(3):257-260. PubMed ID: 35943041
[TBL] [Abstract][Full Text] [Related]
32. Tuberculous epididymo-orchitis following intravesical BCG for superficial bladder cancer.
Bulbul MA; Hijaz A; Beaini M; Araj GF; Tawil A
J Med Liban; 2002; 50(1-2):67-9. PubMed ID: 12841318
[TBL] [Abstract][Full Text] [Related]
33. Influence of the true number of Bacillus Calmette-Guérin instillations on the prognosis of non-muscle invasive bladder tumors.
Portillo JA; Madero R; Solsona E; Fernandez JM; Martínez-Piñeiro L; Palou J; Montesino M; Martínez-Piñeiro JA; Unda M;
Actas Urol Esp; 2014 Jun; 38(5):280-4. PubMed ID: 24529538
[TBL] [Abstract][Full Text] [Related]
34. Tuberculous epididymitis following intravesical Bacillus Calmette-Guérin immunotherapy.
Hoag N; Pommerville PJ; Kibsey PC; Cavers DJ; Eddy RJ
Can J Urol; 2009 Apr; 16(2):4589-91. PubMed ID: 19364433
[TBL] [Abstract][Full Text] [Related]
35. Intravesical Bacillus Calmette-Guerin for treating bladder cancer.
Boyd LA
Urol Nurs; 2003 Jun; 23(3):189-91, 199; quiz 192. PubMed ID: 12861735
[TBL] [Abstract][Full Text] [Related]
36. Adverse reactions related to treatment compliance during BCG maintenance therapy for non-muscle-invasive bladder cancer.
Miyazaki J; Hinotsu S; Ishizuka N; Naito S; Ozono S; Akaza H; Nishiyama H
Jpn J Clin Oncol; 2013 Aug; 43(8):827-34. PubMed ID: 23858038
[TBL] [Abstract][Full Text] [Related]
37. Small bladder and multiple urethral recurrences after intravesical instillation of bacillus Calmette-Guerin for superficial transitional cell carcinoma of the bladder.
Manasia P; Alcaraz A; Cetina A; Alcover J
J Urol; 2001 Feb; 165(2):529-30. PubMed ID: 11176420
[No Abstract] [Full Text] [Related]
38. Safety and efficacy of intravesical bacillus Calmette-Guerin instillations in steroid treated and immunocompromised patients.
Yossepowitch O; Eggener SE; Bochner BH; Donat SM; Herr HW; Dalbagni G
J Urol; 2006 Aug; 176(2):482-5. PubMed ID: 16813873
[TBL] [Abstract][Full Text] [Related]
39. Haemophagocytic syndrome after intravesical bacille Calmette-Guérin instillation.
Misra S; Gupta A; Symes A; Duncan J
Scand J Urol; 2014 Jun; 48(3):328-30. PubMed ID: 24070063
[TBL] [Abstract][Full Text] [Related]
40. Multiple organ failure and granulomatous hepatitis following intravesical bacillus Calmette-Guérin instillation.
Desmet M; Moubax K; Haerens M
Acta Clin Belg; 2012; 67(5):367-9. PubMed ID: 23189546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
